CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
CIGB500 in healthy volunteers	2010-12-20	Registered
THERESA-2 Study	2010-12-20	Registered
Dynamic-I	2010-12-20	Registered
Dermosep-I	2010-12-20	Registered
EPANEM-III	2010-12-20	Registered
AntiCEA M3-I	2010-12-20	Registered
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency.	2010-09-27	Registered
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2010-06-11	Registered
InCroMiel I	2009-12-24	Registered
THERESA-3 Study	2009-12-11	Registered
Safety and immunogenicity of commercial Hepatitis B vaccines.	2009-02-27	Registered
CITOPROT-III	2009-02-26	Registered
Recombinant interferon alpha-2b in paranoid schizophrenia.	2009-02-11	Registered
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis.	2009-02-11	Registered
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C.	2009-02-11	Registered
FASECU I	2008-10-16	Registered
THERESA	2008-10-07	Registered
FarmaPEG-I	2008-10-07	Registered
Jusvinza in rheumatoid arthritis	20/04/2022	Registered
Safety and therapeutic effect of administration of Jusvinza in the post-acute stage of Chikungunya infection	19/11/2025	Registered